Ratings
0
Nobody has rated this yet. Be the first!
Works
5
Long-term therapy with inhaled iloprost in patients with pulmonary hypertension.
Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.
REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat.
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
